| Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells E Kassi, TG Sourlingas, M Spiliotaki, Z Papoutsi, H Pratsinis, N Aligiannis, ... Cancer investigation 27 (7), 723-733, 2009 | 144 | 2009 |
| Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer C Papadaki, M Stratigos, G Markakis, M Spiliotaki, G Mastrostamatis, ... Breast Cancer Research 20, 1-17, 2018 | 71 | 2018 |
| Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients M Spiliotaki, V Salpeas, P Malitas, V Alevizos, P Moutsatsou Psychoneuroendocrinology 31 (6), 748-760, 2006 | 71 | 2006 |
| Caveolin-1 regulates EGFR signalling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition S Agelaki, M Spiliotaki, H Markomanolaki, G Kallergi, D Mavroudis, ... Cancer biology & therapy 8 (15), 1470-1477, 2009 | 67 | 2009 |
| Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy M Spiliotaki, D Mavroudis, K Kapranou, H Markomanolaki, G Kallergi, ... Breast Cancer Research 16, 1-13, 2014 | 62 | 2014 |
| A comparison of three methods for the detection of circulating tumor cells in patients with early and metastatic breast cancer E Politaki, S Agelaki, S Apostolaki, D Hatzidaki, A Strati, F Koinis, ... Cellular Physiology and Biochemistry 44 (2), 594-606, 2017 | 42 | 2017 |
| Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor … M Spiliotaki, H Markomanolaki, M Mela, D Mavroudis, V Georgoulias, ... Lung cancer 73 (2), 158-165, 2011 | 40 | 2011 |
| TAF7 (TAFII55) plays a role in the transcription activation by c-Jun C Munz, E Psichari, D Mandilis, AC Lavigne, M Spiliotaki, T Oehler, ... Journal of Biological Chemistry 278 (24), 21510-21516, 2003 | 34 | 2003 |
| Dynamic monitoring of PD‐L1 and Ki67 in circulating tumor cells of metastatic non‐small cell lung cancer patients treated with pembrolizumab M Spiliotaki, CM Neophytou, P Vogazianos, I Stylianou, G Gregoriou, ... Molecular Oncology 17 (5), 792-809, 2023 | 15 | 2023 |
| Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes M Spiliotaki, D Mavroudis, M Kokotsaki, EK Vetsika, I Stoupis, A Matikas, ... Molecular Oncology 12 (1), 21-32, 2018 | 14 | 2018 |
| Dynamic changes of CTCs in patients with metastatic HR (+)/HER2 (−) breast cancer receiving salvage treatment with everolimus/exemestane M Spiliotaki, G Kallergi, C Nikolaou, N Xenidis, E Politaki, S Apostolaki, ... Cancer Chemotherapy and Pharmacology 87, 277-287, 2021 | 5 | 2021 |
| Evaluation of proliferation and apoptosis markers in circulating tumor cells (CTCs) of women with early breast cancer who are candidates for tumor dormancy M Spiliotaki, H Markomanolaki, G Kallergi, MA Papadaki, V Georgoulias, ... Cancer Research 72 (8_Supplement), 2397-2397, 2012 | 3 | 2012 |
| Abstract P1-01-12: Prevalence of insulin-like growth factor-1 receptor (IGF1R) expression in circulating tumor cells (CTCs) of patients with early breast cancer and its … S Agelaki, M Spiliotaki, M Kokotsaki, A Matikas, EK Vetsika, ... Cancer Research 77 (4_Supplement), P1-01-12-P1-01-12, 2017 | 1 | 2017 |
| 76P Monitoring pembrolizumab response in patients with metastatic non-small cell lung cancer using circulating tumour DNA and circulating tumour cells AC Kakouri, M Spiliotaki, EM Loizidou, I Stylianou, E Papageorgiou, ... ESMO Open 9, 2024 | | 2024 |
| Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer (vol 20, 72, 2018) C Papadaki, M Stratigos, G Markakis, M Spiliotaki, G Mastrostamatis, ... BREAST CANCER RESEARCH 24 (1), 2022 | | 2022 |
| Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer C Papadaki, M Stratigos, G Markakis, M Spiliotaki, G Mastrostamatis, ... Breast Cancer Research: BCR 24, 2022 | | 2022 |
| 25P Evaluation of PD-L1 and Ki67 markers in CTCs of NSCLC patients treated with pembrolizumab M Spiliotaki, H Charalambous, CM Neophytou, G Gregoriou, ... Journal of Thoracic Oncology 16 (4), S709, 2021 | | 2021 |
| Abstract P5-07-10: Circulating microRNAs as early predictors of relapse in operable breast cancer S Agelaki, C Papadaki, M Stratigos, M Spiliotaki, G Markakis, ... Cancer Research 78 (4_Supplement), P5-07-10-P5-07-10, 2018 | | 2018 |
| Circulating microRNAs (miRNAs) as predictors of relapse in early breast cancer (BC). S Agelaki, C Papadaki, M Stratigos, M Spiliotaki, G Markakis, ... Journal of Clinical Oncology 35 (15_suppl), e23030-e23030, 2017 | | 2017 |
| Abstract P1-01-06: Ki67-positive CTCs are associated with early disease relapse in patients with early breast cancer undergoing adjuvant chemotherapy S Agelaki, M Spiliotaki, E Politaki, A Spanaki, L Kassiou, F Koinis, ... Cancer Research 77 (4_Supplement), P1-01-06-P1-01-06, 2017 | | 2017 |
